Compositions and Methods for Modulation of ADAMTS13 Activity
OwnerX. Long Zheng, Ping Zhang +2inventors
InventorsX. Long Zheng, Ping Zhang, Sriram Krishnaswarny, Wenjing Cao
Life of this patent
Estimating the term…
Abstract
Compositions and methods are provided for the diagnosis and treatment of thrombotic thrombocytopenic purpura (TTP), stroke and myocardial infarction.
Claims11
A method for analyzing the VWF cleaving action of ADAMTS13 and variants thereof, comprising:
- a) providing VWF;
- b) contacting said VWF with intact ADAMTS13 and truncated variants thereof under conditions suitable for enzymatic cleavage of VWF;
- c) determining the amount of VWF cleavage in the presence of full length ADAMTS13 relative to that observed in the presence of said truncated variants, thereby identifying a minimal ADAMTS13 sequence suitable to effect cleavage of VWF, said method optionally being performed under flow.
A method for diagnosing TTP in a patient comprising;
- a) obtaining a biological sample comprising VWF and ADAMTS13;
- b) subjecting said sample to vortex induced shear stress;
- and
- c) comparing the level of VWF cleavage in said biological sample relative to an identically treated sample from a normal patient, a reduction in VWF cleavage relative to that observed in said normal patient sample being indicative of TTP.
A method for alleviating the symptoms of a disease in a patient in need thereof, comprising administration of an effective amount of ADAMTS13 and FACTOR VIII in a biologically compatible medium, wherein said disease is selected from the group consisting of TTP, stroke, and myocardial infarction.
Dependencies are inferred from the claim text.